Toggle Main Menu Toggle Search

Open Access padlockePrints

Meeting Report: Psoriasis Stratification to Optimise Relevant Therapy Showcase

Lookup NU author(s): Professor Nick ReynoldsORCiD


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


© 2021 The AuthorsA stratified medicine approach for the treatment of psoriasis promises greater certainty of clinical decision making through prediction of response on the basis of clinical, pharmacological, and -omics data from an individual patient. As yet, there is no predictive model for treatment response in routine clinical use for psoriasis. The Psoriasis Stratification to Optimise Relevant Therapy (PSORT) Consortium is a United Kingdom Medical Research Council‒funded, academic‒industrial stratified medicine consortium established with the objective of discovering the predictors and stratifiers of response of psoriasis to biologic therapies. A showcase meeting was convened and attended by 80 stakeholders at the Royal College of Physicians, London, United Kingdom on 18 November 2019. The purpose was to disseminate the research findings from the PSORT consortium discovered thus far. This report summarizes the presentations made on the day and the significant advances made by PSORT toward a stratified medicine approach to the management of psoriasis.

Publication metadata

Author(s): Yiu ZZN, Barker JNWN, Barnes MR, Di Meglio P, Emsley R, Reynolds NJ, Smith CH, Warren RB, Griffiths CEM

Publication type: Note

Publication status: Published

Journal: Journal of Investigative Dermatology

Year: 2021

Volume: 141

Issue: 8

Pages: 1872-1878

Print publication date: 01/08/2021

Online publication date: 24/03/2021

Acceptance date: 01/02/2021

ISSN (print): 0022-202X

ISSN (electronic): 1523-1747

Publisher: Elsevier B.V.


DOI: 10.1016/j.jid.2021.02.746

PubMed id: 33771529